The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...

In this randomized, controlled, multicenter, international trial, 7376 patients with moderate to very severe COPD who ... with more mild disease or those without previous exacerbations.

Even mild COPD was associated with moderate exacerbations, and patients had an increased prevalence of cardiovascular disease, depression, and anxiety. These investigators looked at the effects of ...

The results of this comparative effectiveness research study suggest that sodium-glucose cotransporter-2 inhibitors  and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a ...

Patients were categorized by contemporary GOLD classification, with GOLD 1 representing mild ... with more severe disease exhibited higher rates of moderate to severe COPD exacerbations, with ...

The following is a summary of “NTHi killing activity is reduced in COPD patients and is associated with a differential ...

researchers noted a higher incidence rate in the severe vs. moderate exacerbation group (15.7 vs. 7.79 per 100 person-years). Considering all COPD exacerbations, the risk for nonfatal ...

Vitamin D deficiency is strongly associated with an increased risk of severe acute exacerbations in patients with chronic ...

Current drug treatments have been incorporated into clinical practice guidelines, such as the NAEPP EPR-3 for asthma [101] and GOLD treatment guidelines for COPD, [102] both of which recognize the ...